Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > REPLICEL LIFE SCIENCES CON GAME
View:
Post by RPINVESTOR1 on Oct 28, 2024 8:36am

REPLICEL LIFE SCIENCES CON GAME

What is going on at Replicel is a con game. 

There has been no news on progress related to the dermal injector in a full year. This withholding of information is most likely deliberate. The lack of information, along with the acceptance by the Board of the one-sided Offer To Purchase in March has caused the stock to slide to $0.02!

Andrew Schutte, CEO, with the help of the Board has put the small shareholders in a very bad situation. Either accept his Offer To Purchase and hope that he will honestly account for all future royaly and asset sales revenue (while further diluting the Company shares by converting worthless options into stock for his 'helpers') or reject the Offer To Purchase and see him convert his 2 million dollar loan into 100 million shares at $0.02 per share. The latter action will give him approximately 70% of the outstanding shares (120 million / 170 million). Either way he wins and we lose!
Comment by MetzGER on Oct 28, 2024 2:04pm
I think we should do a fundraise after that engaging a lawyer. there is a high possibility he whole board members are having a deal with AS  it will be easy for a lawyer to Prove that there are Insider arrangements between the Board members or illegal cashflows. So i really think about getting them in Jail. after loosing so much money the costs of a lawyer are little
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities